Efficacy of CART-19 Cell Therapy in B Cell Acute Lymphoblastic Leukemia
Clinical trial NCT02810223 · UNKNOWN
Trial details
- NCT number
- NCT02810223
- Sponsor
- Beijing Sanwater Biological Technology Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-05-01
- Primary completion
- 2017-12-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.